Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3738578019 | Betamethasone and salicylic acid only product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3738579010 | Product containing only betamethasone and salicylic acid in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Betamethasone and salicylic acid only product in cutaneous dose form | a une forme pharmaceutique (attribut) | forme cutanée | true | Inferred relationship | Some | ||
| Betamethasone and salicylic acid only product in cutaneous dose form | a pour principe actif (attribut) | Salicylic acid (substance) | true | Inferred relationship | Some | 2 | |
| Betamethasone and salicylic acid only product in cutaneous dose form | est un(e) (attribut) | Product containing betamethasone and salicylic acid in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Betamethasone and salicylic acid only product in cutaneous dose form | a pour principe actif (attribut) | Betamethasone | true | Inferred relationship | Some | 1 | |
| Betamethasone and salicylic acid only product in cutaneous dose form | est un(e) (attribut) | Betamethasone and salicylic acid only product | true | Inferred relationship | Some | ||
| Betamethasone and salicylic acid only product in cutaneous dose form | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Betamethasone and salicylic acid only product in cutaneous dose form | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | est un(e) (attribut) | True | Betamethasone and salicylic acid only product in cutaneous dose form | Inferred relationship | Some | |
| Betamethasone (as betamethasone dipropionate) 500 microgram/mL and salicylic acid 30 mg/mL cutaneous lotion | est un(e) (attribut) | True | Betamethasone and salicylic acid only product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR